Third Harmonic Bio, Inc. Common Stock
THRD Real Time Price USDRecent trades of THRD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by THRD's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
THRD Revenue by Segment or Geography
New patents grants
-
Patent Title: Crystalline forms of a selective c-kit kinase inhibitor Sep. 26, 2023
-
Patent Title: Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same Sep. 05, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to THRD
Recent picks made for THRD stock on CNBC
ETFs with the largest estimated holdings in THRD
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $THRD stock a Buy, Sell, or Hold?
- What is the price target for $THRD stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $THRD stock?
- Who owns the most shares of $THRD stock?
- What funds own $THRD stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view THRD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.